Dermatology and COVID-19

Many skin symptoms have been reported in connection with infection with Acute Respiratory Syndrome virus 2 (SARS-CoV-2), which covers almost all inflammatory patterns. The diversity of targeted skin lesions is large compared to other bacterial infections that often have symptoms of skin pattern. High visual prevalence (approximately 20% in one study) in adults, who rarely have viral exanthema, is also important. Lack of testing, as well as possible bias reporting in literature causes problems in understanding the true spread of the findings on the skin. SARS-CoV-2 infection affects people of color equally but there is almost no skin test in this figure.

Skin-related skin problems and measures of personal hygiene, skin rashes detected by SARS-CoV-2 infection, and skin rashes as a result of COVID-19 therapeutic agents.

    Related Conference of Dermatology and COVID-19

    November 22-23, 2024

    4th International Conference on Medical Research and Development

    Aix-en-Provence, France
    November 25-26, 2024

    10th World Congress on Anesthesia and Critical Care

    Paris, France
    April 16-17, 2025

    9th International Conference on Internal Medicine

    Berlin, Germany
    May 12-13, 2025

    19th International Conference on Obesity Medicine

    Toronto, Canada
    June 24-25, 2025

    3rd Global Summit on HIV-AIDS and STDs

    Chicago, USA
    July 16-17, 2025

    11th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France
    August 07-08, 2025

    12th World Summit on Epilepsy and Bipolar Disorders

    Paris, France

    Dermatology and COVID-19 Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in